Yi-Ping Hung, Yu-Yun Shao, Jan-Mou Lee, Chiun Hsu, Chih-Hung Hsu, Muh-Hwa Yang, Yee Chao (2021). Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma. Journal of Chinese Medical Association, 84: 144-150.
Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao (2021). The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma. Journal of the Formosan Medical Association, 120, 1581-1590.
Jan-Mou Lee, Ming-Huang Chen, Kai-Yuan Chou, Yee Chao, Ming-Han Chen, Chang-Youh Tsai (2022). Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response. Lupus Science & Medicine, 9:e000693.
Jan-Mou Lee, Yi-Ping Hung, Kai-Yuan Chou, Cheng-Yun Lee, Shian-Ren Lin, Ya-Han Tsai, Wan-Yu Lai, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, and Yee Chao (2022). Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma. Frontiers in Medicine, 9:1008855.
Shih-Feng Cho, Yi-Chang Liu, Chun-Wei Yu, Chih-Hao Fang, Ya-Fang Cheng, Wan-En Liao, Chia-Chun Tu, Jing-Yao Wang, Shian-Ren Lin, Ya-Han Tsai, Wan-Yu Lai, Li-Tzong Chen, Jan-Mou Lee (2022). Interleukin-12 effectively synergized with interleukin-18 to augment allo-stimulatory activity, cytotoxicity, and CXCR4-mediated chemotaxis of TCRγ9δ2 T cells. International Journal of Molecular Sciences, 23, x.
Yi-Ping Hung, Chia-Chun Tu, Jiun-I Lai, Muh-Hwa Yang, Jan-Mou Lee, and Yee Chao (2024). Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model. BMC Cancer, 24:136.
Chih‑Hao Fang, Wen‑Fang Cheng, Ya‑Fang Cheng, Keng‑Li Lan, and Jan‑Mou Lee (2024). Characterization of tumoricidal activities mediated by a novel immune cell regimen composing interferon-producing killer dendritic cells and tumor-specific cytotoxic T lymphocytes. BMC Cancer, 24:395.